Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FRIEND-VIRUS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 87 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Le Scolan, E; Wendling, F; Barnache, S; Denis, N; Tulliez, M; Vainchenker, W; Moreau-Gachelin, F
      Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts

      ONCOGENE
    2. Prasher, JM; Elenitoba-Johnson, KSJ; Kelley, LL
      Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia

      ONCOGENE
    3. Howard, JC; Li, Q; Chu, W; Zochodne, B; Kapoor, M; Ung, Y; Rosen, K; Ben-David, Y
      Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression

      ONCOGENE
    4. Kitagawa, M; Aizawa, S; Sado, T; Yamaguchi, S; Suzuki, T; Hirokawa, K; Ikeda, H
      A gene therapy model for retrovirus-induced disease with a viral env gene:expression-dependent resistance in immunosuppressed hosts

      LEUKEMIA
    5. Littlewood, TJ; Bajetta, E; Nortier, JWR; Vercammen, E; Rapoport, B
      Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized,double-blind, placebo-controlled trial

      JOURNAL OF CLINICAL ONCOLOGY
    6. Zhang, DY; Johnson, MM; Miller, CP; Pircher, TJ; Geiger, JN; Wojchowski, DM
      An optimized system for studies of EPO-dependent murine pro-erythroblast development

      EXPERIMENTAL HEMATOLOGY
    7. Kendall, RG
      Erythropoietin

      CLINICAL AND LABORATORY HAEMATOLOGY
    8. Yamaguchi, S; Kitagawa, M; Inoue, M; Tejima, Y; Kimura, M; Aizawa, S; Utsuyama, M; Hirokawa, K
      Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia

      MECHANISMS OF AGEING AND DEVELOPMENT
    9. Cheung, W; Minton, N; Gunawardena, K
      Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    10. Blair, DG; Athanasiou, M
      Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis

      ONCOGENE
    11. Safwat, A
      The immunobiology of low-dose total-body irradiation: More questions than answers

      RADIATION RESEARCH
    12. Koszdin, KL; Shen, DD; Bernards, CM
      Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration - The role of P-glycoprotein

      ANESTHESIOLOGY
    13. Patnaik, S; Nayak, BK; Das, BR
      Rearrangement in the coding and 5 ' region of p53 gene in human oral tumors

      IUBMB LIFE
    14. Ruscetti, SK
      Deregulation of erythropoiesis by the Friend spleen focus-forming virus

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    15. Takase-Yoden, S; Watanabe, R
      High incidence of meningeal infiltration by leukemic cells after infectionof chimeric virus between neuropathogenic and non-neuropathogenic retroviruses

      JOURNAL OF NEUROVIROLOGY
    16. Persons, DA; Paulson, RF; Loyd, MR; Herley, MT; Bodner, SM; Bernstein, A; Correll, PH; Ney, PA
      Fv2 encodes a truncated form of the Stk receptor tyrosine kinase

      NATURE GENETICS
    17. Wong, KS; Li, YJ; Howard, J; Ben-David, Y
      Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisitionof mutational events that confers immortality and growth factor independence

      ONCOGENE
    18. Bowden, R; Tate, SM; Soto, S; Specter, S
      Alteration of cytokine levels in murine retrovirus infection: modulation by combination therapy

      INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY
    19. Panoutsakopoulou, V; Hunter, K; Sieck, TG; Blankenhorn, EP; Blank, KJ
      Genetic regulation of long-term nonprogression in E-55+murine leukemia virus infection in mice

      JOURNAL OF VIROLOGY
    20. Hodges, VM; Winter, PC; Lappin, TRJ
      Erythroblasts from Friend virus infected- and phenylhydrazine-treated miceaccurately model erythroid differentiation

      BRITISH JOURNAL OF HAEMATOLOGY
    21. Jackson, MK; Mitchell, EA; Winslow, SG; Okelberry, KM; Sidwell, RW; Morrey, JD
      Resistance to friend leukemia virus in transgenic mice expressing the native FV-4 gene

      ACTA VIROLOGICA
    22. BARNACHE S; WENDLING F; LACOMBE C; DENIS N; TITEUX M; VAINCHENKER W; MOREAUGACHELIN F
      SPI-1 TRANSGENIC MICE DEVELOP A CLONAL ERYTHROLEUKEMIA WHICH DOES NOTDEPEND ON P53 MUTATION

      Oncogene
    23. PANOSKALTSISMORTARI A; EGELER RM; YAEGER TM; YONEJI S; SCHMITZ L; LILLY F; NESBIT ME; BLAZAR BR
      GENETIC AND IMMUNOLOGICAL PARAMETERS GOVERNING IN-VIVO SUSCEPTIBILITYRESISTANCE TO RETROVIRALLY INDUCED MURINE MALIGNANT HISTIOCYTOSIS/

      Journal of leukocyte biology
    24. STOYE JP
      FV1, THE MOUSE RETROVIRUS RESISTANCE GENE

      Revue scientifique et technique - Office international des epizooties
    25. TANG JL; LIPKOWSKI AW; SPECTER S
      INHIBITORY EFFECT OF BIPHALIN AND AZT ON MURINE FRIEND-LEUKEMIA-VIRUSINFECTION IN-VITRO

      International journal of immunopharmacology
    26. Taguchi, T; Fukuda, M; Ohashi, M
      Fidelity levels of DNA polymerases in tumorigenic state cells and seriallytransplantable tumor cells

      MECHANISMS OF AGEING AND DEVELOPMENT
    27. Fang, C; Choi, E; Nie, LG; Li, JP
      Role of the transmembrane sequence of spleen focus-forming virus gp55 in erythroleukemogenesis

      VIROLOGY
    28. DITTMER U; BROOKS DM; HASENKRUG KJ
      CHARACTERIZATION OF A LIVE-ATTENUATED RETROVIRAL VACCINE DEMONSTRATESPROTECTION VIA IMMUNE-MECHANISMS

      Journal of virology
    29. GOMEZLUCIA E; ZHI Y; NABAVI M; ZHANG WB; KABAT D; HOATLIN ME
      AN ARRAY OF NOVEL MURINE SPLEEN FOCUS-FORMING VIRUSES THAT ACTIVATE THE ERYTHROPOIETIN RECEPTOR

      Journal of virology
    30. MIKULITS W; DOLZNIG H; EDELMANN H; SAUER T; DEINER EM; BALLOU L; BEUG H; MULLNER EW
      DYNAMICS OF CELL-CYCLE REGULATORS - ARTIFACT-FREE ANALYSIS BY RECULTIVATION OF CELLS SYNCHRONIZED BY CENTRIFUGAL ELUTRIATION

      DNA and cell biology
    31. FRIEDRICH RW; VEIT M; EISEL D; FRIEDICH U; PASS M; KOZAK CA
      FRE2, A PROVIRAL INTEGRATION SITE OF FRIEND MURINE LEUKEMIA-VIRUS THAT IS CLOSELY LINKED TO FV2

      Leukemia
    32. MATHE G
      HYPOTHETICAL REASONS OF THE HIV-1-AIDS TRITHERAPY FAILURE - A CHALLENGING MODEL

      Biomedicine & pharmacotherapy
    33. MATHE G; MORETTE C; HALLARD M; BLANQUET D
      COMBINATIONS OF 3 OR 4 HIV-1 VIROSTATICS APPLIED IN SHORT SEQUENCES WHICH DIFFER FROM EACH OTHER BY DRUG ROTATION - PRELIMINARY-RESULTS OF THE VIRAL LOADS AND CD4 NUMBERS

      Biomedicine & pharmacotherapy
    34. STAREC M; SINET M; KODYM P; ROSINA J; FISEROVA A; DESFORGES B; ROUVEIX B
      THE EFFECT OF DRUGS ON THE MORTALITY OF MICE INOCULATED WITH FRIEND-LEUKEMIA VIRUS OR TOXOPLASMA-GONDII

      Physiologia bohemoslovaca
    35. QUANG CT; WESSELY O; PIRONIN M; BEUG H; GHYSDAEL J
      COOPERATION OF SPI-1 PU.1 WITH AN ACTIVATED ERYTHROPOIETIN RECEPTOR INHIBITS APOPTOSIS AND EPO-DEPENDENT DIFFERENTIATION IN PRIMARY ERYTHROBLASTS AND INDUCES THEIR KIT LIGAND-DEPENDENT PROLIFERATION/

      EMBO journal
    36. LANDER JK; FAN H
      LOW-FREQUENCY LOSS OF HETEROZYGOSITY IN MOLONEY MURINE LEUKEMIA VIRUS-INDUCED TUMORS IN BRAKF1 J MICE/

      Journal of virology
    37. TARR K; WATOWICH SS; LONGMORE GD
      CELL-SURFACE ORGANIZATION OF THE ERYTHROPOIETIN RECEPTOR COMPLEX DIFFERS DEPENDING ON ITS MODE OF ACTIVATION

      The Journal of biological chemistry
    38. NIHRANE A; SILVER J
      SPONTANEOUS PRIMING FOR ANTIVIRAL ENVELOPE CYTOTOXIC T-LYMPHOCYTES INMICE TRANSGENIC FOR A MURINE LEUKEMIA-VIRUS ENVELOPE GENE (FV4)

      Immunology
    39. VANNUCCHI AM; LINARI S; CELLAI C; KOURY MJ; PAOLETTI F
      CONSTITUTIVE AND INDUCIBLE EXPRESSION OF MEGAKARYOCYTE-SPECIFIC GENESIN FRIEND-ERYTHROLEUKEMIA CELLS

      British Journal of Haematology
    40. BITTORF T; BUSFIELD SJ; KLINKEN SP; TILBROOK PA
      TRUNCATED ERYTHROPOIETIN RECEPTOR IN A MURINE ERYTHROLEUKEMIA CELL-LINE

      International journal of biochemistry & cell biology
    41. KITAGAWA M; AIZAWA S; IKEDA H; HIROKAWA K
      ESTABLISHMENT OF A THERAPEUTIC MODEL FOR RETROVIRAL INFECTION USING THE GENETIC-RESISTANCE MECHANISM OF THE HOST

      Pathology international
    42. HOWARD J; UNG Y; ADACHI D; BENDAVID Y
      P53-INDEPENDENT TUMOR-GROWTH AND IN-VITRO CELL-SURVIVAL FOR F-MULV-INDUCED ERYTHROLEUKEMIAS

      Cell growth & differentiation
    43. MATHE G; PONTIGGIA P; ORBACHARBOUYS S; TRIANA K; AMBETIMA N; MORETTE C; HALLARD M; BLANQUET D
      AIDS THERAPY WITH 2, 3 OR 4 AGENT COMBINATIONS, APPLIED IN SHORT SEQUENCES, DIFFERING FROM EACH OTHER BY DRUG ROTATION .1. FIRST OF 2 PARTS- A PHASE-I TRIAL EQUIVALENT, CONCERNING 5 VIROSTATICS - AZT, DDI, DDC, ACRIFLAVINE AND AN ELLIPTICINE ANALOG

      Biomedicine & pharmacotherapy
    44. MATHE G; COLASANTE U; MORETTE C; HALLARD M; BLANQUET D
      WILL KILLING THE LAST HIV-1 PARTICLE CURE AIDS PATIENTS.2. DECREASE OF VIRAL LOAD AND OF T-SUPPRESSOR CELLS, AND INCREASE OF THE CYTOTOXIC-CELLS, WITHOUT EFFECT ON CD4, AFTER THE USE OF 10 VIROSTATICS APPLIED IN 3 OR 4 DRUG-COMBINATIONS OF DIFFERENT SEQUENCES - THE TIME FOR CD4 IMMUNOTHERAPY

      Biomedicine & pharmacotherapy
    45. MATHE G; HALLARD M; PONTIGGIA P
      LYMPHANGIOGRAPHIC STUDY OF PELVIC ADENOPATHY REGRESSION IN A PHASE-IITRIAL OF METHYL-HYDROXY-ELLIPTICINE IN HIV-1-AIDS COMPLEX

      Biomedicine & pharmacotherapy
    46. BLOBEL GA; ORKIN SH
      ESTROGEN-INDUCED APOPTOSIS BY INHIBITION OF THE ERYTHROID TRANSCRIPTION FACTOR GATA-1

      Molecular and cellular biology
    47. SIN JI; PLOTNIKOFF N; SPECTER S
      ANTIRETROVIRAL ACTIVITY OF METHIONINE-ENKEPHALIN AND AZT IN A MURINE CELL-CULTURE

      International journal of immunopharmacology
    48. FUKASAWA K; CHOI T; KURIYAMA R; RULONG S; VANDEVOUDE GF
      ABNORMAL CENTROSOME AMPLIFICATION IN THE ABSENCE OF P53

      Science
    49. BAXTER EW; BLYTH K; DONEHOWER LA; CAMERON ER; ONIONS DE; NEIL JC
      MOLONEY MURINE LEUKEMIA VIRUS-INDUCED LYMPHOMAS IN P53-DEFICIENT MICE- OVERLAPPING PATHWAYS IN TUMOR-DEVELOPMENT

      Journal of virology
    50. HASENKRUG KJ; BROOKS DM; NISHIO J; CHESEBRO B
      DIFFERING T-CELL REQUIREMENTS FOR RECOMBINANT RETROVIRUS VACCINES

      Journal of virology
    51. MIYACHI Y
      MARKED DEPRESSION OF RADIATION-INDUCED EMESIS BY OLFACTORY BULBECTOMYOR PREEXPOSURE USING LOW-DOSES

      Experientia
    52. HARVEY M; VOGEL H; MORRIS D; BRADLEY A; BERNSTEIN A; DONEHOWER LA
      A MUTANT P53 TRANSGENE ACCELERATES TUMOR-DEVELOPMENT IN HETEROZYGOUS BUT NOT NULLIZYGOUS P53 DEFICIENT MICE

      Nature genetics
    53. QUANG CT; PIRONIN M; VONLINDERN M; BEUG H; GHYSDAEL J
      SPI-1 AND MUTANT P53 REGULATE DIFFERENT ASPECTS OF THE PROLIFERATION AND DIFFERENTIATION CONTROL OF PRIMARY ERYTHROID PROGENITORS

      Oncogene
    54. XU X; YAMAMURA Y; TSUKADA T; YOSHIDA MA; SENDA H; NAGAYOSHI M; IKEUCHI T; IKAWA Y
      A MOUSE ERYTHROLEUKEMIA CELL-LINE POSSESSING FRIEND SPLEEN FOCUS-FORMING VIRUS GP55 TRANSGENE AND TEMPERATURE-SENSITIVE MUTANT P53 GENE

      Japanese journal of cancer research
    55. MACLEOD KF; SHERRY N; HANNON G; BEACH D; TOKINO T; KINZLER K; VOGELSTEIN B; JACKS T
      P53-DEPENDENT AND INDEPENDENT EXPRESSION OF P21 DURING CELL-GROWTH, DIFFERENTIATION, AND DNA-DAMAGE

      Genes & development
    56. ABRAHAMSON JLA; LEE JM; BERNSTEIN A
      REGULATION OF P53-MEDIATED APOPTOSIS AND CELL-CYCLE ARREST BY STEEL FACTOR

      Molecular and cellular biology
    57. IKEDA T; TAKASEYODEN S; WATANABE R
      CHARACTERIZATION OF MONOCLONAL-ANTIBODIES RECOGNIZING NEUROTROPIC FRIEND MURINE LEUKEMIA-VIRUS

      Virus research
    58. LEE JM; BERNSTEIN A
      APOPTOSIS, CANCER AND THE P53 TUMOR-SUPPRESSOR GENE

      Cancer metastasis reviews
    59. LIMJOCO T; NIHRANE A; SILVER J
      RESISTANCE TO RETROVIRAL INFECTION IN TRANSGENIC AND BONE-MARROW CHIMERIC MICE CONTAINING FV4-ENV-EXPRESSING HEMATOPOIETIC-CELLS

      Virology
    60. CARROLL M; ZHU Y; DANDREA AD
      ERYTHROPOIETIN-INDUCED CELLULAR-DIFFERENTIATION REQUIRES PROLONGATIONOF THE G(1) PHASE OF THE CELL-CYCLE

      Proceedings of the National Academy of Sciences of the United Statesof America
    61. HASENKRUG KJ; BROOKS DM; CHESEBRO B
      PASSIVE IMMUNOTHERAPY FOR RETROVIRAL DISEASE - INFLUENCE OF MAJOR HISTOCOMPATIBILITY COMPLEX TYPE AND T-CELL RESPONSIVENESS

      Proceedings of the National Academy of Sciences of the United Statesof America
    62. ROUVEIX B; VEYRIES ML
      EFFECTS OF MORPHINE ON THE PATHOGENESIS O F MURINE FRIEND RETROVIRUS INFECTION

      Bulletin de l'Academie nationale de medecine
    63. BLONDAL JA; BENCHIMOL S
      THE ROLE OF P53 IN TUMOR PROGRESSION

      Seminars in cancer biology
    64. RUBIN J; CHARBONEAU JW; READING C; KOVACH JS
      PHASE-I STUDY OF IMMUNOTHERAPY OF HEPATIC METASTASES OF COLORECTAL-CARCINOMA BY DIRECT GENE-TRANSFER

      Human gene therapy
    65. CAHEN P; GRUNWALD D; PIGOTT D; BROCARD MP; KHOCHBIN S; LAWRENCE JJ
      CHARACTERIZATION OF A MUTATED P53 EXHIBITING A CELL CYCLE-RELATED NUCLEAR TRANSLOCATION

      International journal of oncology
    66. HROMAS R; KLEMSZ M
      THE ETS ONCOGENE FAMILY IN DEVELOPMENT, PROLIFERATION AND NEOPLASIA

      International journal of hematology
    67. SAWYER ST; PENTA K
      ERYTHROPOIETIN CELL BIOLOGY

      Hematology/oncology clinics of North America
    68. MATHE G; PONTIGGIA P; BOURUT C; CHENU E; ORBACHARBOUYS S
      IN-VIVO ERADICATION OF FRIEND-VIRUS AS AN EXPERIMENTAL HIV-MODEL, BY COMBINATION OF ZIDOVUDINE, ACRIFLAVINE AND AN ELLIPTICINE ANALOG - POSSIBLE APPLICATION TO THE TREATMENT OF HUMAN PRE-AIDS

      Biomedicine & pharmacotherapy
    69. SOLDAINI E; BALDINOTTI F; MATTEUCCI D; SPECTER S; BENDINELLI M
      ENHANCEMENT OF PLASMA-LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA BUT NOT INTERLEUKIN-6 FOLLOWING ENDOTOXIN INJECTION OF FRIEND-LEUKEMIA VIRUS-INFECTED MICE

      Journal of biological regulators and homeostatic agents
    70. SHEN RN; LU L; YOUNG P; SHIDNIA H; HORNBACK NB; BROXMEYER HE
      INFLUENCE OF ELEVATED-TEMPERATURE ON NATURAL-KILLER-CELL ACTIVITY, LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY AND LECTIN-DEPENDENT CYTOTOXICITY OF HUMAN UMBILICAL-CORD BLOOD AND ADULT-BLOOD CELLS

      International journal of radiation oncology, biology, physics
    71. VOLKER J; GEYER H; GEYER R
      GLYCOSYLATION OF GLYCOPROTEIN 55 ENCODED BY THE ANEMIA-INDUCING STRAIN OF FRIEND SPLEEN FOCUS-FORMING VIRUS

      Glycoconjugate journal
    72. KELLEY LL; GREEN WF; HICKS GG; BONDURANT MC; KOURY MJ; RULEY HE
      APOPTOSIS IN ERYTHROID PROGENITORS DEPRIVED OF ERYTHROPOIETIN OCCURS DURING G(1)-PHASE AND S-PHASE OF THE CELL-CYCLE WITHOUT GROWTH ARREST OR STABILIZATION OF WILD-TYPE P53

      Molecular and cellular biology
    73. LONGMORE GD; PHARR PN; LODISH HF
      A CONSTITUTIVELY ACTIVATED ERYTHROPOIETIN RECEPTOR STIMULATES PROLIFERATION AND CONTRIBUTES TO TRANSFORMATION OF MULTIPOTENT, COMMITTED NONERYTHROID AND ERYTHROID PROGENITOR CELLS

      Molecular and cellular biology
    74. MALO D; SKAMENE E
      GENETIC-CONTROL OF HOST-RESISTANCE TO INFECTION

      Trends in genetics
    75. OJWANG J; OKLEBERRY KM; MARSHALL HB; VU HM; HUFFMAN JH; RANDO RF
      INHIBITION OF FRIEND MURINE LEUKEMIA-VIRUS ACTIVITY BY GUANOSINE THYMIDINE OLIGONUCLEOTIDES/

      Antiviral research
    76. STEWART DR; KIRSCHMANN DA; BLANK KJ; MURASKO DM
      DIFFERENCES BETWEEN YOUNG AND AGED MICE IN SUSCEPTIBILITY TO FRIEND-VIRUS

      Mechanism of ageing and development
    77. CORBIN A; RICHARDSON J; DENESVRE C; POZO F; ELLERBROK H; SITBON M
      THE ENVELOPES OF 2 ECOTROPIC MURINE LEUKEMIA VIRUSES DISPLAY DISTINCTEFFICIENCIES IN RETROVIRAL VACCINATION BY INTERFERENCE

      Virology
    78. LEVINE AJ
      THE ROAD TO THE DISCOVERY OF THE P53 PROTEIN - THE STEINER-CANCER-PRIZE-AWARD-LECTURE

      International journal of cancer
    79. CALVO V; WOOD M; GJERTSON C; VIK T; BIERER BE
      ACTIVATION OF 70-KDA S6 KINASE, INDUCED BY THE CYTOKINES INTERLEUKIN-3 AND ERYTHROPOIETIN AND INHIBITED BY RAPAMYCIN, IS NOT AN ABSOLUTE REQUIREMENT FOR CELL-PROLIFERATION

      European Journal of Immunology
    80. HERMINE O; DONG YJ; GOLDWASSER E
      EFFECTS OF BUTYRATE ON THE ERYTHROPOIETIN RECEPTOR OF CELL-LINE IW201

      Blood
    81. WU B; SHEN RN; WANG WX; BROXMEYER HE; LU L
      ANTITUMOR EFFECT OF INTERLEUKIN-7 IN COMBINATION WITH LOCAL HYPERTHERMIA IN MICE BEARING B16A MELANOMA-CELLS

      Stem cells
    82. HOWARD JC; YOUSEFI S; CHEONG G; BERNSTEIN A; BENDAVID Y
      TEMPORAL-ORDER AND FUNCTIONAL-ANALYSIS OF MUTATIONS WITHIN THE FLI-1 AND P53 GENES DURING THE ERYTHROLEUKEMIAS INDUCED BY F-MULV

      Oncogene
    83. MATHE G; CHENU E; BOURUT C; ORBACHARBOUYS S
      THE IN-VIVO EFFECT OF ELLIPTICINE ANALOGS ON THE BLOOD-CONCENTRATION OF FRIEND-VIRUS - A MURINE MODEL FOR STUDYING ANTI-HIV DRUGS

      Biomedicine & pharmacotherapy
    84. STEVENSON NR; LENARD J
      ANTIRETROVIRAL ACTIVITIES OF HYPERICIN AND ROSE-BENGAL - PHOTODYNAMICEFFECTS ON FRIEND-LEUKEMIA VIRUS-INFECTION OF MICE

      Antiviral research
    85. LUKE W; POLZIEN F; SCHARF JG; HUNSMANN G
      BIOCHEMICAL AND IMMUNOLOGICAL CHARACTERIZATION OF MICELLAR COMPLEXES OF THE ENVELOPE GLYCOPROTEIN OF A SIMIAN IMMUNODEFICIENCY VIRUS ISOLATED FROM AN AFRICAN-GREEN MONKEY

      Journal of virological methods
    86. YAMAMOTO Y; SPECTER S; FRIEDMAN H
      LIPOPOLYSACCHARIDE RESTORES ANTI-CANDIDA-ALBICANS GROWTH-INHIBITION ACTIVITY OF POLYMORPHONUCLEAR NEUTROPHILS FROM RETROVIRUS-IMMUNOSUPPRESSED MICE

      Infection and immunity
    87. FAXVAAG A; ESPEVIK T; DALEN A
      MULTIPLE DERANGEMENTS OF CYTOKINE HOMEOSTASIS IN MICE INFECTED WITH IMMUNOSUPPRESSIVE RETROVIRUS

      Cellular immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 15:21:48